Johnson Robert Anthony 4/A

What Happened

• Robert Anthony Johnson, SVP & Chief Supply Chain Officer at DENTSPLY SIRONA (XRAY), was granted 471,400 derivative awards on 2025-11-07. The Form 4 lists the grant as an acquisition (code A) with $0 cash paid at grant because these are option/award rights, not an immediate stock purchase.
• Footnote: the options will cliff‑vest and become exercisable on the third anniversary of the grant date, with an exercise price equal to 110% of the closing price of XRAY common stock on the grant date (i.e., the strike is 10% above the grant‑date close).

Key Details

• Transaction date: 2025-11-07 (reported via an amended filing on 2026-03-06).
• Transaction type/code: Award/Grant (A); derivative (options) shown with $0 acquisition value on the Form 4.
• Shares/units granted: 471,400 option awards.
• Shares owned after transaction: Not disclosed on this Form 4.
• Footnote: Options cliff‑vest and become exercisable three years after grant; exercise price = 110% of grant‑date closing price.
• Filing timeliness: This is an amended filing (filed 2026-03-06 for a 2025-11-07 transaction), indicating the original report was late.

Context

• These are option awards (derivatives), not exercised shares. They do not generate immediate proceeds or share sales; they give the insider the right to buy shares later if and when vested and exercised.
• Because the exercise price is set at 110% of the grant‑date close, the options are initially out‑of‑the‑money (strike 10% above the grant‑date close) and require stock appreciation before exercise would be profitable.